Syncona Portfolio Ltd

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 7, 2025), Syncona Portfolio Ltd reported 2 stock positions worth $26.4 million. Its top holding was Autolus Therapeutics (AUTL) at 97.8% of the portfolio, followed by Century Therapeutics (IPSC, 2.2%). Compared with Q4 2024, it sold out of 1. The biggest sale was an exit from Achilles Therapeutics PL-ADR (ACHL).

Most Recent 13F
Q2 2026
Location
St Peter Port, Guernsey, X0
CIK
0001725042
Portfolio Value
$26.4M (Q1 2025)
SEC Filing
0000950123-25-004190 ↗ filed May 7, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $150.1M Q1 2024 Q2 2024: $85.9M Q2 2024 Q3 2024: $80.7M Q3 2024 Q4 2024: $53.0M Q4 2024 Q1 2025: $26.4M $26.4M Q1 2025 Q2 2025: $38.6M Q2 2025 Q3 2025: $27.7M Q3 2025 Q4 2025: $34.3M Q4 2025 Q1 2026: $25.7M Q1 2026 Q2 2026: $26.6M Q2 2026

Holdings 2 stocks · $26.4M
AUTL Autolus Therapeutics PLC 97.81% 16,640,720 $25.8M No change
IPSC Century Therapeutics Inc. 2.19% 1,213,056 $577K No change

Portfolio Sells Q4 2024 → Q1 2025
ACHL Achilles Therapeutics PL-ADR Sold out 0.00% −23.86

Portfolio Buys Q4 2024 → Q1 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$26.6MAUTL
Q1 2026 2$25.7MAUTL, IPSC
Q4 2025 2$34.3MAUTL, IPSC
Q3 2025 2$27.7MAUTL, IPSC
Q2 2025 2$38.6MAUTL, IPSC
Q1 2025 2$26.4MAUTL, IPSC
Q4 2024 3$53.0MAUTL, ACHL, IPSC
Q3 2024 3$80.7MAUTL, ACHL, IPSC
Q2 2024 3$85.9MAUTL, ACHL, IPSC
Q1 2024 2$150.1MAUTL, ACHL